| Subject: | FDA Approves New Screening Test for Inherited Diseases of the Newborn |
| Category: | Food and Drug Administration (FDA)
|
| Published: | Fri, 10 Sep 2004 - 10:00 am |
| The FDA announced approval of the NeoGram Amino Acids and Acylcarnitines Tandem Mass Spectrometry Kit, a new screening blood test that will help practitioners detect inherited metabolic diseases of the newborn. The new test, manufactured by PerkinElmer Life and Analytical Sciences, Inc., is a heel stick blood sample taken from the newborn to check levels of amino acids, free carnitine and acylcarnitines (with abnormally high levels indicating inborn errors of metabolism disease states in the... The full article is available to StayAlert subscribers. Click here for a free trial subscription. |
|
RESOURCES:
External Links:
Related MCN Products:
|
|
StayAlert!® Virtual Compliance Administrator™ keeps clients informed by email of any changes to Federal regulations, including Joint Commission (TJC, formerly JCAHO), CDC, CMS, DHHS, FDA, OSHA, OIG, and many more, and also provides downloadable tools to ensure compliance. StayAlert! is a premium product sold as an annual site-license subscription. With the site license, the client can sign up an unlimited number of users for the email alerts and access to the StayAlert! online regulatory library. Currently StayAlert! is the leader in the comprehensive compliance information marketplace. Why? Because StayAlert! provides healthcare professionals with more than information. StayAlert! provides a service, in many cases "doing the work" for you, and assisting regulatory compliance officers to effectively and efficiently meet changing standards. |
|
